Unknown

Dataset Information

A designed cyclic analogue of gomesin has potent activity against Staphylococcus aureus biofilms.


ABSTRACT:

Background

Infections caused by bacterial biofilms are very difficult to treat. The use of currently approved antibiotics even at high dosages often fails, making the treatment of these infections very challenging. Novel antimicrobial agents that use distinct mechanisms of action are urgently needed.

Objectives

To explore the use of [G1K,K8R]cGm, a designed cyclic analogue of the antimicrobial peptide gomesin, as an alternative approach to treat biofilm infections.

Methods

We studied the activity of [G1K,K8R]cGm against biofilms of Staphylococcus aureus, a pathogen associated with several biofilm-related infections. A combination of atomic force and real-time confocal laser scanning microscopies was used to study the mechanism of action of the peptide.

Results

SUBMITTER: Dias SA 

PROVIDER: S-EPMC9704431 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature